Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2017. Start Trial.
Date Value
November 12, 2026 60.66B
November 11, 2026 60.43B
November 10, 2026 60.05B
November 09, 2026 59.48B
November 06, 2026 57.31B
November 05, 2026 55.30B
November 04, 2026 57.57B
November 03, 2026 55.70B
November 02, 2026 54.08B
October 30, 2026 55.19B
October 29, 2026 55.49B
October 28, 2026 55.12B
October 27, 2026 54.54B
October 26, 2026 53.73B
October 23, 2026 54.00B
October 22, 2026 54.13B
October 21, 2026 55.01B
October 20, 2026 53.75B
October 19, 2026 51.02B
October 16, 2026 50.62B
October 15, 2026 52.30B
October 14, 2026 50.57B
October 13, 2026 49.60B
October 12, 2026 50.20B
October 09, 2026 50.99B
Date Value
October 08, 2026 50.59B
October 07, 2026 57.39B
October 06, 2026 57.52B
October 05, 2026 56.42B
October 02, 2026 56.82B
October 01, 2026 57.86B
September 30, 2026 59.27B
September 29, 2026 60.00B
September 28, 2026 60.10B
September 25, 2026 59.31B
September 24, 2026 59.48B
September 23, 2026 58.46B
September 22, 2026 59.57B
September 21, 2026 61.09B
September 18, 2026 61.22B
September 17, 2026 61.55B
September 16, 2026 60.87B
September 15, 2026 60.56B
September 14, 2026 61.23B
September 11, 2026 60.85B
September 10, 2026 60.83B
September 09, 2026 61.96B
September 08, 2026 62.25B
September 04, 2026 63.87B
September 03, 2026 65.12B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Autolus Therapeutics Plc 508.24M
Cellectis SA 71.36M
Halozyme Therapeutics, Inc. 13.65B
DBV Technologies SA 574.77M
Akari Therapeutics Plc 4.334M

Enterprise Value Related Metrics